EndoChoice, a platform-technology company, provides devices, diagnostics, infection control and imaging for specialists treating a wide range of gastrointestinal diseases.
EndoChoice currently has over 2,500 customers and distribution in 34 countries worldwide, and was recently recognized for the third consecutive year as one of the fastest growing companies in the U.S. by Inc. Magazine.
